Latest Breaking News On - Basilea pharmaceutica international ltd - Page 1 : comparemela.com

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea

Allschwil, Switzerland, May 16, 2024 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal.

Basel stadtUnited statesSwitzerland generalAsia pacificNils schrDavid veitchHead of corporate communications investor relationsPfizer incBasilea pharmaceutica international ltdSwiss exchangeEuropean unionBasilea pharmaceutica ltdPharmaceutica ltdChief executive officerCorporate communicationsPharmaceutica international ltd

federalregister.gov - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from federalregister.gov Daily Mail and Mail on Sunday newspapers.

Puerto ricoUnited statesNew jerseyState of marylandNew londonNew yorkState of connecticutAmerican samoaDistrict of columbiaNorthern mariana islandsMarshall islandsAl iskandariyahThree statesVirgin islandsWest virginiaUniversity of illinois

Basilea Pharmaceutica AG: Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024

Basilea Pharmaceutica AG: Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Switzerland generalBasel stadtComunidad autonoma de catalunaUnited statesVg fowler jrMarc engelhardtNils schrHuman servicesAdministration for strategic preparednessEuropean society of clinical microbiologyBasilea pharmaceutica international ltdBiomedical advanced researchDevelopment authoritySwiss exchangeBasilea pharmaceutica ltdDrug administration

Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024

Allschwil, Switzerland, May 03, 2024 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal.

United statesSwitzerland generalBasel stadtComunidad autonoma de catalunaFowler jrMarc engelhardtNils schrBiomedical advanced researchHuman servicesUs department of healthHead of corporate communications investor relationsInternational journal of antimicrobial agentsBasilea pharmaceutica ltdDrug administrationSwiss exchangeBasilea pharmaceutica international ltd

Basilea shareholders approve all proposals of the board of directors at the annual general meeting

Allschwil, Switzerland, April 24, 2024 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal.

Basel stadtSwitzerland generalLeonard kruimerMartin nicklassonNicole onettoThomas wernerDomenico scalaCaroline cronNils schrBasilea pharmaceutica international ltdPricewaterhousecoopers ltdBasilea pharmaceutica ltdSwiss exchangeHead of corporate communications investor relationsPharmaceutica ltdCarole sable